baber/WOPTO huggingface dataset:
Patent CA-2644046-A1 (CA)
Inventor: ZENG LING
IPC: A61P3/00
Filed: 2007-02-23
Abstract: The present invention relates to metabolic regulators that affect metabolic function, for example metabolic regulators that affect muscle mass, muscle regeneration, muscle hypertrophy, fat mass, insulin and glucose sensitivity, angiogenesis and cardiovascular function. In particular, the present invention relates to modulating metabolic function by administering an effective amount of a pharmaceutical composition comprising an agent, where the agent activates or inhibits the activity and/or gene expression of the metabolic regulator. The metabolic regulators of the present invention are, for example MSPl (2160028F08Rik; SEQ ID NO: 16); MSP2 (2310043I08Rik; SEQ ID NO: 17); MSP3 (NM_026754;l 110017116Rik;SEQ ID NO: 1); MSP4 (4732466D17Rik; SEQ BD NO:18); MSP 5 (NM_024237; 1600015H20Rik; SEQ ID NO:12); Insl6 (AF_156094; SEQ ID NO:20). The present invention also provides methods to screen for agents that affect the metabolic regulators of the present invention.
Patent CA-2644887-A1 (CA)
Inventor: PHIPPS PAUL B
IPC: B60N2/90
Filed: 2008-11-26
Abstract: A system comprises a vehicle seating system including a seat and at least one powered seat adjustment actuator for altering the seating position forme d by the seat. Additionally, the system includes a vehicle braking system including vehicle brakes and a brake pedal. The system further includes a signal sent in response to application of the vehicle brakes and/or other triggering events, such as tu rn signal activation and others which leads to suspension of movement of the actuator during application of the vehicle brakes.
Patent CA-2646295-A1 (CA)
Title: Needled glass mat
Inventor: BASSANI EMILIO
IPC: C03C25/26
Filed: 2007-03-20
Abstract: The invention relates to a needled glass mat comprising a mineral glass strand sized by a composition comprising water, the solids content of said composition comprising 1% to 30% by weight of a coupling agent and 30% to 99% by weight of polyvinylpyrrolidone. The invention also relates to a process for preparing a mat that comprises a) depositing or projecting sized strands onto a moving belt in order to form a web of said strands which is driven by said belt; then b) needling using barbed needles that pass through said web and that move in the direction of the web at substantially the same speed as the web when they pass through it, with a punch density ranging from 1 to 25 punches per cm2. This process is rapid and effective, and the mat obtained is easily deformed by hand in order to be placed into a mould for manufacturing a composite by resin transfer moulding (RTM). This mat may also be incorporated into a sheet moulding compound (SMC) and may be pressure-moulded.
Patent CA-2646616-A1 (CA)
Title: Method and apparatus for secure management of debugging processes within communication devices
Inventor: MEDVINSKY ALEXANDER
IPC: G06F21/22
Filed: 2008-12-12
Abstract: A method, device and system for securely managing debugging processes within a communication device, such as a set top box or other multimedia processing device. For example, a security processor (SP) within the communication device manages t he lifetime (LT) of any access token issued for use in activating debugging privileges within the communication device. The security processor authenticates an issued access token and securely delivers appropriate debug authorization information to the device controller. The security processor uses its secure, internal timer to count down the lifetime and update the remaining lifetime of the issued access token during the processi ng of each command by the security processor. In addition to securely managing the issuance of the access token and it's remaining lifetime, the updating process reduces any impact on the normal communications within the device. The method overcomes the issue of t he communication device not having a secure internal clock.
Patent CA-2648706-A1 (CA)
Title: Monitoring system
Inventor: COVERZIN DENNIS A
IPC: G10L15/22
Filed: 2007-04-20
Abstract: Systems, methods and techniques are described for monitoring a subject. The subject's safety, health and wellbeing can be monitoring using a system that receives input indicating the subject's status. The system can verbally interact with the subject to obtain information on the subject's status. The words used by the subject or the quality of the subject's response can be used to decide whether to contact emergency services to assist the subject.
Patent CA-2650850-A1 (CA)
Title: Electrochemical oxidation of organic matter
Inventor: NAIR VINOD
IPC: C10G1/06
Filed: 2007-05-04
Abstract: Carbonaceous feedstock is at least partially oxidized using a concentrated metal ion solution that is regenerated in an electrochemical hydrogen gas producing process. The at least partially oxidized feedstock and/or hydrogen are then advantageously used as an energy carrier in a downstream process.
Patent CA-2651625-A1 (CA)
Inventor: FOSTER SIMON EDWARD
IPC: H01M8/02
Filed: 2007-05-14
Abstract: A gasket for sealing internal surfaces of a fuel cell and formed of compressible material, the gasket comprising a first sealing surface and a second sealing surface for providing a fluid seal against opposing faces of a first fluid flow field plate and a second fluid flow field plate respectively, the gasket further comprising a third sealing surface for sealing against an outer perimeter region of a first surface of a membrane electrode assembly, the third sealing surface being entirely enclosed within a boundary defined by an inner perimeter of the second sealing surface.
Patent CA-2652452-A1 (CA)
Inventor: HOROWITZ LAWRENCE
IPC: C12Q1/68
Filed: 2007-05-15
Abstract: The present invention concerns methods and means for identifying, producing, and engineering neutralizing antibodies against influenza A viruses, and to the neutralizing antibodies produced. In particular, the invention concerns neutralizing antibodies against various influenza A virus subtypes, including neutralizing antibodies against two or more of Hl, H2, H3, H5, H7 and H9, such as, for example all of Hl, H2, H3, and H5 subtypes, and methods and means for making such antibodies. More specifically, the invention concerns antibodies capable of neutralizing more than one, preferably all, isolates of an influenza A virus subtype.
Patent CA-2652860-A1 (CA)
Inventor: LIND JEFFERSON CRAIG
IPC: G06F19/00
Filed: 2007-05-31
Abstract: A result level structure includes a number of first result levels and a second result level. Each first result level correlates a respective result level identifier and a respective result value. Each first result level is also associated with a respective expected number of results per given number of plays in a game. As with each first result level, the second result level is associated with a respective expected number of results per given number of plays in the game. In contrast to the first result levels, however, the second result level correlates a respective result level identifier and a respective user definable result value field which may hold any suitable result value designated by a game operator. Thus, the second result level represents a user alterable result level.
Patent CA-2653297-A1 (CA)
Title: Pivoting, multi-configuration mobile device
Inventor: LOWLES ROBERT J
IPC: G06F15/02
Filed: 2007-05-30
Abstract: A mobile device (200) comprises a display portion (204) and a keypad portion (202). The display portion (204) has a front side that includes a display screen (206) and a back side. The keypad portion (202) is rotatably coupled to the display portion (204) between a plurality of operational configurations. The keypad portion (202) has a front side that includes a plurality of input devices (208-225), (231-245) and an outer edge, with the front side of the keypad portion (202) having a depressed area (205) surrounding and including an area where the keypad portion (202) and display portion (204) are rotatably coupled. At least one of the plurality of input devices (231-245) is situated in the depressed area (205). The front side of the keypad portion (202) and the front side of the display portion (204) face in the same direction while rotating between the plurality of operational configurations. The plurality of operational configurations includes at least a first configuration and a second configuration.
Patent CA-2653818-A1 (CA)
Title: Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
Inventor: LOECHEL STEVEN CHARLES
IPC: A61P25/00
Filed: 2007-05-29
Abstract: This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their use in the manufacture of pharmaceutical compositions. The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. Ar represents a phenyl group, which phenyl is substituted with methylenedioxy or ethylenedioxy.
Patent CA-2655692-A1 (CA)
Inventor: NEIDHART WERNER
IPC: A61P3/10
Filed: 2007-06-26
Abstract: Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
Patent CA-2658165-A1 (CA)
Title: Process for the preparation of tiotropium bromide
Inventor: BUSOLLI JONATHAN
IPC: C07D451/10
Filed: 2007-07-10
Abstract: The invention is directed to improved processes for preparing Tiotropium bromide using scopine salts.
Patent CA-2661285-A1 (CA)
Title: Method and apparatus for the detection of living phytoplankton cells in water
Inventor: KROON BERND
IPC: C02F1/00
Filed: 2007-08-01
Abstract: The invention relates to a method and an apparatus for detecting living phytoplankton cells and/or microorganisms in or out of water, particularly ballast water, bodies of water, sewage, or water in swimming and bathing devices. Said method is characterized by the following steps: - the variable fluorescence (Fv) is calculated by forming the difference between the maximum fluorescence (Fm) and the minimum fluorescence (Fo) in a measuring space or detecting part or all of the dynamic shape of a fluorescence induction curve in a measuring space, particularly measuring; and - calculating the number of living phytoplankton cells and/or microorganisms of a reference species in the measuring space in accordance with the variable fluorescence (Fv).
Patent CA-2661620-A1 (CA)
Title: A safety device
Inventor: MASURIER STEVEN LE
IPC: E06C7/44
Filed: 2007-08-28
Abstract: A safety device, comprising: a mounting arrangement operable to receive and support a lower portion of a ladder; and a support assembly upon which the device may rest, the support assembly comprising a plurality of elongate support members, each of which has a pair of ground contacting locations on which the device may rest and is independently pivotable with respect to the mounting arrangement around a point located between the ground contacting locations.
Patent CA-2662337-A1 (CA)
Inventor: OSSOVSKAYA VALERIA
IPC: A61K31/50
Filed: 2007-09-05
Abstract: The present invention relates to a method of treating a fatty acid synthesis related disease comprising administering to a patient in need thereof an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis, wherein the fatty acid synthesis related disease is obesity, diabetes, or cardiovascular disease. The present invention also relates to a method of treating a cancer in a subject comprising: (i) identifying a level of fatty acid in a sample from the subject, and (ii) administering an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis in the subject, wherein the administration is based on the level of fatty acid, thereby treating the cancer in the subject. The present invention further relates to a method of treating Her-2 related cancers by administering to a patient in need thereof an effective amount of a PARP inhibitor or metabolite thereof to inhibit fatty acid synthesis.
Patent CA-2663437-A1 (CA)
Title: Aerodynamic element and wing with aerodynamic element, actuator-activation module, computer, computer program, and method for influencing wake eddies
Inventor: ALLEN ALEXANDER
IPC: B64C13/16
Filed: 2007-09-15
Abstract: The invention relates to an aerodynamic body (4) for applying to a carrier wing on which at least two flow flaps (5a, 5b) adjacently arranged in the longitudinal direction of the aerodynamic body are mounted, to a carrier wing comprising a main carrier wing (2) and the at least one additional aerodynamic body, and to a computer comprising an actuating drive control module which generates time-variable command signals for actuating drives. The actuating drive control module has a function which, when activated, generates at least two oscillatory command signals on each actuator drive, said signals being in opposition of phase. The invention also relates to a computer program for implementing in a computer with an actuating drive control module, to a method for influencing command signals for an actuating drive system, and to combinations of such a computer with an actuating drive control module, a carrier wing, and at least one actuating drive.
Patent CA-2664788-A1 (CA)
Title: Fluid connection system for endoscope reprocessing with controlled leakage
Inventor: MAPSON TARA DENISE
IPC: A61B1/227
Filed: 2001-02-07
Abstract: An intraluminally implantable stent is formed of helically wound wire. The stent has a generally elongate tubular configuration and is radially expandable after implantation in a body vessel. The wire includes successively formed waves along the length of the wire.  When helically wound into a tube, the waves are longitudinally nested along the longitudinal extent of the stent so as to form a densely compacted wire configuration.  After radial expansion the stent maintains high radial compressive strength and wire density to retard tissue ingrowth.
Patent CA-2666061-A1 (CA)
Title: Capacitor bank switching
Inventor: FOLTS DOUGLAS C
IPC: H02J3/18
Filed: 2000-11-21
Abstract: The invention features a system (30) and approach for minimizing the step voltage change as seen by the utility customer as well minimizing transients imposed on the fundamental waveform of a normal voltage carried on a utility power network when a reactive power source (31) (e.g., capacitor bank) is instantaneously connected to the utility power network. The reactive power source (31) is adapted to transfer reactive power of a first polarity (e.g., capacitive reactive power) to the utility power network. The system includes a reactive power compensation device (32, 44, 52) configured to transfer a variable quantity of reactive power of a second, opposite polarity to the utility power network, and a controller (60) which, in response to the need to connect the shunt reactive power source (31) to the utility power network, activates the reactive power compensation device (32, 44, 55) and, substantially simultaneously, causes the shunt reactive power source (31) to be connected to the utility power.
Patent CA-2667022-A1 (CA)
Inventor: ZOBELE FRANCO
IPC: A61L9/03
Filed: 2007-10-19
Abstract: The present invention relates to an electric evaporator device of volatile substances with adjustable evaporation intensity. A heating plate (4) defines a first chamber (6) separated from a second chamber (8), wherein a heat generator (5) is located inside the first chamber (6). A regulation opening (13), located in the first chamber (6), allows the exit of a heated air flow from the first chamber to regulate the temperature both in the first chamber (6) and the heating plate (4), enabling thus the regulation of the evaporation rate.
Patent CA-2667283-A1 (CA)
Inventor: MONCLA BRAD M
IPC: B29B15/10
Filed: 2007-10-16
Abstract: An article including at least one layer of a compound disposed on at least a portion of a glass-containing substrate, wherein the compound includes a polyolefin having a deformation temperature of less than 110°C and a dispersion stabilizing agent, wherein the compound imparts a modified property to the substrate, and wherein the substrate is formable. Other embodiments include a compound in contact with a portion of a glass-containing substrate, such as glass-containing or glass-based articles and fibers, wherein the compound at the time of contacting included an aqueous dispersion having (a) a polyolefin having a deformation temperature of less than 110°C, (b) a dispersion stabilizing agent; and (c) water, wherein the compound imparts a modified property to the substrate, and wherein the substrate is formable.
Patent CA-2667580-A1 (CA)
Inventor: KOTTILINGAL SUDEEP RAVI
IPC: H04L29/06
Filed: 2007-11-07
Abstract: The disclosure is directed to managing registration of a wireless communication device (WCD) operating in a wireless network. The WCD may support registration according to a signaling protocol, such as session initiation protocol (SIP). The WCD adjusts a registration timer based on network quality experienced by the WCD. When network quality is poor, for example, the WCD reduces the length of the registration timer. Reduced network quality may indicate that the WCD is at risk of losing network coverage. By reducing the length of the registration timer when network quality is degraded, stale registrations for out-of-coverage WCDs can be reduced. In particular, the shortened registration timer will expire more quickly, permitting the registration to be cleared more quickly. Consequently, the amount of call forwarding and other resources devoted to stale registrations can be reduced. If the WCD retains network coverage, it can maintain a registration by sending another registration request.
Patent CA-2668394-A1 (CA)
Inventor: PRASAD DURGA YANDAPALLI
IPC: C05F11/02
Filed: 2007-11-02
Abstract: A novel functionally effective organic molecules with various molecular weights are produced by cleaving lignite with hydrogen peroxide or alkaline hydrogen peroxide predominantly below 1000 molecular weight, the said functionally effective organic molecules, molecular weights varies depending on the reaction conditions such as concentration of hydrogen peroxide, time of reaction, temperature, ratio of lignite to hydrogen peroxide, lignite quality etc. conditions. These organic molecules are functionally effective than normal organic molecules (humic, fulvic acids etc.) present naturally in lignite or leonardite due to enhanced reactive nature obtained by treating with hydrogen peroxide or alkaline hydrogen peroxide which are resultant of cleavage of lignite. These functionally effective organic molecules have utilities in various areas such as agriculture and medicine.
Patent CA-2670030-A1 (CA)
Title: Method for blocking roaming-steering mechanisms
Inventor: LEBL TOMAS
IPC: H04W8/12
Filed: 2007-07-07
Abstract: The invention relates to a method for blocking roaming steering mechanisms. According to said method, a foreign cellular device (3), e.g. a cellular telephone, is registered with a nationally visited radio network (2) when the foreign (1) and the national cellular network operator have concluded a roaming agreement on mutually debiting cellular services. The invention is characterized in that an anti-roaming steering server (5) installed in the nationally visited cellular network (2) identifies manipulated error messages (14) and selectively manipulates the registration process (8) of foreign mobile users by adequately influencing signaling processes.
Patent CA-2671912-A1 (CA)
Inventor: URBANIAK STANISLAW JOSEPH
IPC: G01N33/68
Filed: 2006-12-05
Abstract: The present invention relates to a method of identifying an immunologically effective epitope, the method comprising: a) preparing an oligomer of a protein present on the surface of a red blood cell which includes a polymorphism therein and b) ascertaining whether the oligomer stimulates T-cells and a composition comprising an immunologically effective epitope for the tolerisation of a subject that has been exposed to an antithetical allele.
Patent CA-2672938-A1 (CA)
Title: System and method for electronic commerce and other uses
Inventor: SERBANESCU RAZZ
IPC: G06Q30/00
Filed: 2007-12-18
Abstract: One embodiment of the present invention relates to a computer implemented method, comprising: storing, at a central server, an initialize business rule associated with a vendor and a DNS associated with the vendor, wherein the DNS comprises an address of a data store of the vendor; receiving, from a user, at the central server, a first user query, wherein the first user query requests a product or service of the vendor; dynamically forming in real-time at the central server a universal code sequence forming a DNA field, wherein the universal code sequence is associated with the first query, at least a part of the sequence being hierarchal; wherein the universal codes comprise at least a field projecting a user identity, a-field projecting a transaction scope and a field projecting a product definition; sending the initialize business rule from the central server to the DNS, wherein the initialize business rule causes the vendor to execute the initialize business rule; receiving, from the vendor, at the central server, a first vendor response, wherein the first vendor response is based at least in part upon execution by the vendor of the initialize business rule and the first vendor response includes at least one next business rule; receiving, from the user, at the central server, a second user query, wherein the second user query is a selection from a choice based upon the first vendor response; dynamically adding to the universal code sequence in real-time at the central server to form a request DNA, wherein the addition comprises a universal code associated with the selection; sending at least one of the at least one next business rules from the central server to the DNS, wherein the next business rule that is sent is associated with the selection and wherein the next business rule that is sent causes the vendor to execute the next business rule that is sent; receiving from the vendor, at the central server, a second vendor response, wherein the second vendor response is based at least in part upon execution by the vendor of the next business rule that is sent; dynamically forming in real¬ time, at the central server, an offer DNA, wherein the offer DNA is based at least in part upon the request DNA and the second vendor response; and wherein the offer DNA comprises universal codes including at least a field projecting a vendor identity, a field projecting a transaction scope and a field projecting a product definition; determining, at the central server, that the offer DNA matches the request DNA as to at least the field projecting a product definition; and sending to at least one of the user and to the vendor, from the central server, a notification that the offer DNA matches the request DNA.